Lvw Advisors Holding In Chevron New (CVX) Was Has Raised; Biogen (BIIB) Holder Hudson Bay Capital Management LP Trimmed Stake as Market Valuation Declined

February 17, 2018 - By Dolores Ford

Lvw Advisors Llc increased its stake in Chevron Corp New (CVX) by 179.75% based on its latest 2017Q3 regulatory filing with the SEC. Lvw Advisors Llc bought 4,553 shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 7,086 shares of the integrated oil company at the end of 2017Q3, valued at $833,000, up from 2,533 at the end of the previous reported quarter. Lvw Advisors Llc who had been investing in Chevron Corp New for a number of months, seems to be bullish on the $213.00 billion market cap company. The stock decreased 0.35% or $0.39 during the last trading session, reaching $112.14. About 5.95 million shares traded. Chevron Corporation (NYSE:CVX) has risen 6.68% since February 17, 2017 and is uptrending. It has underperformed by 10.02% the S&P500.

Sander Gerber decreased its stake in Biogen Inc (BIIB) by 57.14% based on its latest 2017Q3 regulatory filing with the SEC. Hudson Bay Capital Management Lp sold 20,000 shares as the company’s stock declined 13.45% while stock markets rallied. The hedge fund run by Sander Gerber held 15,000 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $4.70M, down from 35,000 at the end of the previous reported quarter. Hudson Bay Capital Management Lp who had been investing in Biogen Inc for a number of months, seems to be less bullish one the $61.75 billion market cap company. The stock decreased 2.51% or $7.51 during the last trading session, reaching $291.87. About 2.94 million shares traded or 122.72% up from the average. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 17, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Investors sentiment decreased to 0.95 in Q3 2017. Its down 0.08, from 1.03 in 2017Q2. It dived, as 43 investors sold CVX shares while 696 reduced holdings. 121 funds opened positions while 584 raised stakes. 1.18 billion shares or 1.43% more from 1.16 billion shares in 2017Q2 were reported. 50,096 were accumulated by Kentucky Retirement Insurance Fund. Bridgewater Associates Limited Partnership accumulated 31,298 shares. Congress Asset Mngmt Com Ma holds 364,478 shares. Wagner Bowman Management holds 17,346 shares or 0.57% of its portfolio. Amarillo Financial Bank accumulated 8,400 shares. Arvest Bancorp Trust Division accumulated 153,582 shares. Haverford Incorporated accumulated 2,250 shares or 0.1% of the stock. Leisure Capital reported 2.12% stake. Harvey Invest Co Ltd Liability Co accumulated 17,549 shares or 0.41% of the stock. Tokio Marine Asset Mngmt Ltd invested in 0.78% or 43,948 shares. Pettee Investors Incorporated, a Connecticut-based fund reported 23,424 shares. Systematic Mgmt Ltd Partnership reported 62,398 shares stake. Cv Starr & Co owns 30,000 shares for 1.63% of their portfolio. Olstein Capital Mngmt Limited Partnership invested 0.26% in Chevron Corporation (NYSE:CVX). Oppenheimer Incorporated reported 148,049 shares stake.

Lvw Advisors Llc, which manages about $2.12B and $251.82M US Long portfolio, decreased its stake in Ishares Tr (HEFA) by 48,452 shares to 49,216 shares, valued at $1.42M in 2017Q3, according to the filing. It also reduced its holding in Ishares Tr (AGG) by 142,544 shares in the quarter, leaving it with 52,998 shares, and cut its stake in Procter And Gamble Co (NYSE:PG).

Since August 16, 2017, it had 0 buys, and 1 insider sale for $3.06 million activity. Deily Linnet F sold 2,312 shares worth $248,274.

Among 34 analysts covering Chevron Corporation (NYSE:CVX), 24 have Buy rating, 0 Sell and 10 Hold. Therefore 71% are positive. Chevron Corporation had 114 analyst reports since August 4, 2015 according to SRatingsIntel. As per Friday, February 9, the company rating was upgraded by RBC Capital Markets. As per Thursday, December 1, the company rating was upgraded by Independent Research. Jefferies maintained the shares of CVX in report on Tuesday, October 3 with “Buy” rating. The firm has “Overweight” rating by PiperJaffray given on Tuesday, August 9. As per Tuesday, November 15, the company rating was upgraded by CLSA. The company was upgraded on Friday, March 11 by Goldman Sachs. The firm has “Neutral” rating given on Monday, February 5 by Credit Suisse. BMO Capital Markets maintained the stock with “Buy” rating in Thursday, June 22 report. The rating was maintained by Barclays Capital on Tuesday, October 10 with “Equal-Weight”. The firm earned “Buy” rating on Wednesday, December 2 by Citigroup.

Among 33 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 24 have Buy rating, 0 Sell and 9 Hold. Therefore 73% are positive. Biogen Idec Inc. had 113 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by Argus Research with “Buy” on Monday, July 27. The rating was maintained by Jefferies on Wednesday, October 5 with “Hold”. On Wednesday, January 24 the stock rating was maintained by Canaccord Genuity with “Hold”. Morgan Stanley upgraded the shares of BIIB in report on Thursday, October 5 to “Overweight” rating. The firm has “Neutral” rating by Citigroup given on Tuesday, June 7. The firm earned “Neutral” rating on Wednesday, January 20 by Credit Suisse. Raymond James maintained Biogen Inc. (NASDAQ:BIIB) on Tuesday, August 2 with “Strong Buy” rating. The firm earned “Buy” rating on Thursday, February 25 by Citigroup. The company was maintained on Friday, March 11 by Robert W. Baird. As per Monday, June 19, the company rating was upgraded by UBS.

Hudson Bay Capital Management Lp, which manages about $4.18B and $4.02B US Long portfolio, upped its stake in Altaba Inc by 835,526 shares to 3.78 million shares, valued at $250.22 million in 2017Q3, according to the filing. It also increased its holding in Northern Dynasty Minerals Lt (Call) by 1.58M shares in the quarter, for a total of 2.48M shares, and has risen its stake in Golar Lng Ltd Bermuda (Call).

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.25, from 0.88 in 2017Q2. It increased, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Kansas-based Mitchell Capital Mngmt has invested 2.17% in Biogen Inc. (NASDAQ:BIIB). Pub Employees Retirement Of Ohio has invested 0.24% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Bamco Inc New York accumulated 12,951 shares. Reynders Mcveigh Capital Llc has 0.19% invested in Biogen Inc. (NASDAQ:BIIB) for 4,675 shares. Boltwood Capital Management has 0.53% invested in Biogen Inc. (NASDAQ:BIIB) for 2,610 shares. Federated Invsts Pa invested in 0% or 3,705 shares. Sumitomo Life Insur Co holds 0.28% or 6,949 shares in its portfolio. Peapack Gladstone Financial, a New Jersey-based fund reported 2,781 shares. Raymond James Finance Svcs Advsr stated it has 23,278 shares or 0.05% of all its holdings. Moreover, Cornerstone Limited Liability Company has 0.11% invested in Biogen Inc. (NASDAQ:BIIB). Inv Partners Oh Adv has 0.27% invested in Biogen Inc. (NASDAQ:BIIB). Macquarie Grp Inc holds 0.39% or 698,232 shares in its portfolio. Moreover, Levin Capital Strategies Limited Partnership has 0.02% invested in Biogen Inc. (NASDAQ:BIIB). Wesbanco Fincl Bank has 1,469 shares for 0.02% of their portfolio. Peddock Capital Advsrs Lc reported 2,374 shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>